Valrubicin
- Generic Name
- Valrubicin
- Brand Names
- Valstar
- Drug Type
- Small Molecule
- Chemical Formula
- C34H36F3NO13
- CAS Number
- 56124-62-0
- Unique Ingredient Identifier
- 2C6NUM6878
Overview
Valrubicin (N-trifluoroacetyladriamycin-14-valerate) is a chemotherapy drug commonly marketed under the trade name VALSTAR. It is a semisynthetic analog of the doxorubicin, which is an anthracycline drug. Used in the treatment of the bladder cancer, valrubicin is administered by direct infusion into the bladder.
Background
Valrubicin (N-trifluoroacetyladriamycin-14-valerate) is a chemotherapy drug commonly marketed under the trade name VALSTAR. It is a semisynthetic analog of the doxorubicin, which is an anthracycline drug. Used in the treatment of the bladder cancer, valrubicin is administered by direct infusion into the bladder.
Indication
For the treatment of cancer of the bladder.
Associated Conditions
- In situ BCG-refractory Bladder carcinoma
Clinical Trials
FDA Approved Products
Singapore Approved Products
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.